These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 34923574)
1. Prostate cancer risk in men of differing genetic ancestry and approaches to disease screening and management in these groups. McHugh J; Saunders EJ; Dadaev T; McGrowder E; Bancroft E; Kote-Jarai Z; Eeles R Br J Cancer; 2022 Jun; 126(10):1366-1373. PubMed ID: 34923574 [TBL] [Abstract][Full Text] [Related]
2. Screening for prostate cancer. Ilic D; Neuberger MM; Djulbegovic M; Dahm P Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD004720. PubMed ID: 23440794 [TBL] [Abstract][Full Text] [Related]
3. Genetic predisposition to prostate cancer. Benafif S; Eeles R Br Med Bull; 2016 Dec; 120(1):75-89. PubMed ID: 27941040 [TBL] [Abstract][Full Text] [Related]
4. The use of multiphase nonlinear mixed models to define and quantify long-term changes in serum prostate-specific antigen: data from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Shoaibi A; Rao GA; Cai B; Rawl J; Hébert JR Ann Epidemiol; 2016 Jan; 26(1):36-42.e1-2. PubMed ID: 26611771 [TBL] [Abstract][Full Text] [Related]
5. Genetic predisposition to prostate cancer: an update. Ni Raghallaigh H; Eeles R Fam Cancer; 2022 Jan; 21(1):101-114. PubMed ID: 33486571 [TBL] [Abstract][Full Text] [Related]
6. Prostate Specific Antigen-Growth Curve Model to Predict High-Risk Prostate Cancer. Shoaibi A; Rao GA; Cai B; Rawl J; Haddock KS; Hébert JR Prostate; 2017 Feb; 77(2):173-184. PubMed ID: 27699819 [TBL] [Abstract][Full Text] [Related]
7. Self-Identified African Americans and prostate cancer risk: West African genetic ancestry is associated with prostate cancer diagnosis and with higher Gleason sum on biopsy. Grizzle WE; Kittles RA; Rais-Bahrami S; Shah E; Adams GW; DeGuenther MS; Kolettis PN; Nix JW; Bryant JE; Chinsky R; Kearns JE; Dehimer K; Terrin N; Chang H; Gaston SM Cancer Med; 2019 Nov; 8(16):6915-6922. PubMed ID: 31568648 [TBL] [Abstract][Full Text] [Related]
8. Genetics of prostate cancer: a review of latest evidence. Hall R; Bancroft E; Pashayan N; Kote-Jarai Z; Eeles RA J Med Genet; 2024 Sep; 61(10):915-926. PubMed ID: 39137963 [TBL] [Abstract][Full Text] [Related]
9. Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement. ; Grossman DC; Curry SJ; Owens DK; Bibbins-Domingo K; Caughey AB; Davidson KW; Doubeni CA; Ebell M; Epling JW; Kemper AR; Krist AH; Kubik M; Landefeld CS; Mangione CM; Silverstein M; Simon MA; Siu AL; Tseng CW JAMA; 2018 May; 319(18):1901-1913. PubMed ID: 29801017 [TBL] [Abstract][Full Text] [Related]
10. Screening for prostate cancer with the prostate-specific antigen test: a review of current evidence. Hayes JH; Barry MJ JAMA; 2014 Mar; 311(11):1143-9. PubMed ID: 24643604 [TBL] [Abstract][Full Text] [Related]
11. Influence of blood prostate specific antigen levels at age 60 on benefits and harms of prostate cancer screening: population based cohort study. Carlsson S; Assel M; Sjoberg D; Ulmert D; Hugosson J; Lilja H; Vickers A BMJ; 2014 Mar; 348():g2296. PubMed ID: 24682399 [TBL] [Abstract][Full Text] [Related]
12. Race, genetic West African ancestry, and prostate cancer prediction by prostate-specific antigen in prospectively screened high-risk men. Giri VN; Egleston B; Ruth K; Uzzo RG; Chen DY; Buyyounouski M; Raysor S; Hooker S; Torres JB; Ramike T; Mastalski K; Kim TY; Kittles R Cancer Prev Res (Phila); 2009 Mar; 2(3):244-50. PubMed ID: 19240249 [TBL] [Abstract][Full Text] [Related]
13. Screening asymptomatic men for prostate cancer: A comparison of international guidelines on prostate-specific antigen testing. Jackson SD; de la Rue MR; Greenslade TP; John AM; Wahid S; Martin RM; Williams NJ; Turner EL J Med Screen; 2022 Dec; 29(4):268-271. PubMed ID: 36062629 [TBL] [Abstract][Full Text] [Related]
14. Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis. Ilic D; Djulbegovic M; Jung JH; Hwang EC; Zhou Q; Cleves A; Agoritsas T; Dahm P BMJ; 2018 Sep; 362():k3519. PubMed ID: 30185521 [TBL] [Abstract][Full Text] [Related]
15. Prostate cancer disparities in South Carolina: early detection, special programs, and descriptive epidemiology. Drake BF; Keane TE; Mosley CM; Adams SA; Elder KT; Modayil MV; Ureda JR; Hebert JR J S C Med Assoc; 2006 Aug; 102(7):241-9. PubMed ID: 17319238 [TBL] [Abstract][Full Text] [Related]
16. Prostate-Specific Antigen-Based Screening for Prostate Cancer: Evidence Report and Systematic Review for the US Preventive Services Task Force. Fenton JJ; Weyrich MS; Durbin S; Liu Y; Bang H; Melnikow J JAMA; 2018 May; 319(18):1914-1931. PubMed ID: 29801018 [TBL] [Abstract][Full Text] [Related]
17. Prostate-Specific Antigen (PSA)-Based Population Screening for Prostate Cancer: An Evidence-Based Analysis. Pron G Ont Health Technol Assess Ser; 2015; 15(10):1-64. PubMed ID: 26366236 [TBL] [Abstract][Full Text] [Related]
18. [Consensus of prostate cancer screening]. Prostate Cancer Working Group of Genitourinary Cancer Committee in Chinese Anti-Cancer Association Zhonghua Wai Ke Za Zhi; 2017 May; 55(5):340-342. PubMed ID: 28464572 [TBL] [Abstract][Full Text] [Related]
19. Family History of Prostate Cancer and Survival Outcomes in the UK Genetic Prostate Cancer Study. Brook MN; Ní Raghallaigh H; Govindasami K; Dadaev T; Rageevakumar R; Keating D; Hussain N; Osborne A; Lophatananon A; ; Muir KR; Kote-Jarai Z; Eeles RA Eur Urol; 2023 Mar; 83(3):257-266. PubMed ID: 36528478 [TBL] [Abstract][Full Text] [Related]